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rajeshprajapati@gAbstract A novel, safe, economic and sensitive method of spectrophotometric estimation has been
developed using Azeoptropic mixture (water:methanol: 60:40, v/v) for the quantitative determina-
tion of Lornoxicam, a practically water-insoluble drug. Hence, Lornoxicam stock solution was
prepared in Azeoptropic mixture. Lornoxicam showed maximum absorbance at 383 nm. Beer’s law
was obeyed in the concentration range 4–24 mg/mL with regression coefﬁcient of 0.999. The method
was validated in terms of linearity (R2¼0.999), precision (CV for intra-day and inter-day was 0.28–
0.68 and 0.12–0.92, respectively), accuracy (98.03–100.59% w/w) and speciﬁcity. This method is
simple, precise, accurate, sensitive and reproducible and can be used for the routine quality control
testing of the marketed formulations.
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All liquid mixtures have forces of intermolecular attraction.
That is why they form liquids and not gases. The molecular
interactions when two or more components are mixed may
cause the mixture to form certain ‘‘inseparable’’ compositions
where the vapor and liquid compositions at equilibrium are
equal within a given pressure and temperature range. These
speciﬁc mixture compositions are called azeotropes [1,2].
These azeotropes are forming nonideal solutions but due to
this it will increase the solubility power of the other solvent. So
we are using the same principle for spectrophotometric study
of Lornoxicam.
Spectrophotometric estimation using Azeoptropic mixture for the quantitative determination of Lornoxicam 307Lornoxicam (chlortenoxicam) is a non-steroidal anti-
inﬂammatory drug (NSAID) of the oxicam class with analge-
sic, anti-inﬂammatory and antipyretic properties, is available
in oral and parenteral formulations [3].
Lornoxicam (LOR) differs from other oxicam compounds in
its potent inhibition of prostaglandin biosynthesis, a property
that explains the particularly pronounced efﬁcacy of the drug.
Extensive literature survey reveals there are various methods
reported for the estimation of LOR in pharmaceutical for-
mulations in combination with other drugs by HPLC and
other spectroscopic methods [4–9] but there were no any
reported methods that use azeotropic mixture as solvent.
Though LOR is not practically soluble in water all the methods
used organic solvents for estimation of LOR which was not
economic as well as environment-friendly. So we have applied
concept of azeotropes and combine organic solvent and water
to make method economic and environment-friendly (Fig. 1).2. Materials and methods
2.1. Materials
UV1700 series (Shimadzu, Japan) and Beckman UV–visible
double beam spectrophotometer Lambda 19 (Perkin Elmer,Figure 1 Chemical structure of Lornoxicam [5].
Figure 2 Overlain spectra of LOR (4–24 mg/mL) inUSA) using a 1 cm quartz cells were used for absorbance
measurements. Standard of Lornoxicam was gift sample from
Macleods Pharmaceuticals Ltd. Vapi, Gujarat and tablets were
procured from the local market (Lorox, Marketed by Dyota).
Whatmann ﬁlter paper no. 42 was used to ﬁlter the solutions.
2.2. Methods
2.2.1. Preparation of standard stock solution
A 10 mg of LOR (Lornoxicam) standard was weighed and
transferred to a 25 mL volumetric ﬂask. 10 mL mixture of
methanol and water (40:60, v/v) was transferred to volumetric
ﬂask and sonicated for 5 min. The ﬂask was shaken and the
volume was made up to the mark with the mixture of
methanol and water (40:60, v/v) to give a solution containing
400 mg/mL LOR. From this solution 5 mL was transferred to
a 25 mL volumetric ﬂask. The volume was adjusted to the
mark with the mixture of methanol and water (40:60, v/v) to
give a solution containing 80 mg/mL LOR.
2.2.2. Selection of analytical wavelength
The solution of LOR at concentrations of 4–24 mg/mL was
prepared in the mixture of methanol and water (40:60, v/v)
and spectra were recorded between 200 and 600 nm. LOR
showed lmax at wavelength 383 nm. The overlain spectra of
LOR at different concentrations were recorded.
2.2.3. Calibration curve for LOR
Appropriate volume of aliquots from standard LOR stock
solution was transferred to different volumetric ﬂasks of 10 mL
capacity. The volume was adjusted to the mark with mixture of
methanol and water (40:60, v/v) to obtain concentrations of 4,the mixture of methanol and water (40:60, v/v).
P. Prajapati et al.3088, 12, 16, 20 and 24 mg/mL. The curve of solution against the
mixture of methanol and water (40:60, v/v) was recorded.
2.3. Determination of Lornoxicam in tablet dosage form
2.3.1. Sample preparation
Twenty tablets were weighed and ﬁnely powered. Powder equiva-
lent to 10 mg LOR was accurately weighed and transferred to
volumetric ﬂask of 25 mL capacity. 15 mL of the mixture of
methanol and water (40:60, v/v) was transferred to volumetric ﬂask
and sonicated for 5 min. The ﬂask was shaken and volume was
made up to the mark with the mixture of methanol and water
(40:60, v/v). The above solution was ﬁltered through Whatman
ﬁlter paper (0.45 mm). From this solution 5 mL was transferred to
volumetric ﬂask of 25 mL capacity. The volume was made up to
the mark to give a solution containing 80 mg/mL LOR (Solution A).
From the solution A, 1.5 mL was transferred to volumetric
ﬂask of 10 mL capacity. The volume was made up to the markTable 1 Regression analysis data of calibration curves
prepared by the proposed method.
Concentration
(mg/mL)
Absorbance at 383 nm
(Mean7SDa)
CV
4 0.148870.0018 1.190
8 0.293870.0008 0.276
12 0.445670.0015 0.343
16 0.609470.0021 0.342
20 0.786670.0023 0.294
24 0.937770.0011 0.121
aSix replicate samples.
Figure 3 Calibration curve of LOR at 383 nm.
Table 2 Results of analysis of Lornoxicam formulation.
Amount of drug in tablet
powder taken (mg)
Amount found (mg)
Formulation 1 Form
8 7.92 7.91
8 7.89 7.93
8 7.99 7.84
Formulation 1 is Lornoxi 8 mg; marketed by Hetero HC.
Formulation 2 is Lorox 8 mg; marketed by Dyota.with the mixture of methanol and water (40:60, v/v) to give a
solution containing 12 mg/mL LOR (Solution 1). This solution
was used for the estimation of LOR.
2.3.2. Estimation of LOR in tablet dosage form
The solution 1 was measured at 383 nm for quantiﬁcation of
LOR. The amount of LOR present in the sample solution was
determined. From the absorbance obtained in the spectrum,
the amount of drug was calculated.3. Results and discussion
3.1. Method validation
As per the ICH guidelines [10,11], spectra for concentration
range 4–24 mg/mL were obtained with n¼6 (Fig. 2, Table 1).
Absorbance at 383 nm was measured and the plot of absor-
bance vs. concentration was plotted. The straight-line equa-
tion was determined (Fig. 3). The proposed method obeys
Beer’s law in the concentration range 4–24 mg/mL. In this
method, the correlation coefﬁcient (R2) was found to be 0.999,
the slope was 0.0399 and the intercept was 0.0217.
3.1.1. Accuracy
To investigate the accuracy in sample preparation (i.e., extraction
efﬁciency), we prepare a spiked solution by adding known
amounts of related substances into a sample matrix. Thereafter
responses of the spiked solutions and the neat standard solutions
were taken to assess the recovery from the sample preparation.
In this stage, 20 tablets were taken, analysis of the sample was
carried out and the results of analysis are shown in Table 2.
Recovery studies were carried out by addition of standard drug
to the sample at three different concentration levels taking into
consideration percentage purity of added bulk drug samples. The
method was found to be accurate with % recovery 98.03–
100.59% for LOR (Table 3).
3.1.2. Precision
The experiment was repeated three times in a day to determine
intra-day precision and on three different days to determine
inter-day precision. The coefﬁcient of variance (CV) was calcu-
lated at each concentration level. As shown in Table 4, CV for
intra-day and inter-day was 0.28–0.68 and 0.12–0.92, respec-
tively. The reproducibility was conﬁrmed by repeating the
methods and robustness study was also carried out at variable
conditions, then the percent relative standard deviation (% RSD)
was calculated.Percentage estimated
ulation 2 Formulation 1 Formulation 2
99.02 98.87
98.71 99.10
99.95 98.03
Table 4 Precision data for LOR at 383 nm.
Conc.
(mg/mL)
Intra-day (n¼3) Inter-day (n¼3)
Detected
concentration
(Mean7SD,
mg/mL)
CV Detected
concentration
(Mean7SD,
mg/mL)
CV
8 7.9470.03 0.385 7.9870.07 0.827
12 12.0170.06 0.485 11.9670.04 0.366
16 15.9770.05 0.287 16.0770.02 0.126
Table 3 Results of recovery study of Lornoxicam.
Amt. of sample
LOR (mg/mL)
Amt. of drug
added LOR
(mg/mL)
Amt. of drug
recovered
(mg/mL)
Recovery
(%)
12 0 11.91 –
12 6 5.98 99.38
12 12 11.92 99.39
12 18 17.83 99.08
Table 5 Summary of validation parameters of
spectrophotometry.
Parameters Values
lmax (nm) 383
Beer’s Law limit (mg/mL) 4–24
Molar absorptivity (L/mol cm) 3.9 102
Regression equation (Ya)
Slope (b) 0.0399
Intercept (c) 0.0217
Correlation coefﬁcient (r)b 0.999
Recovery (%) 98.86–100.26
Repeatability (RSD, n¼6) 0.343
Precision(CV)
Intra-dayb 0.28–0.68
Inter-dayb 0.12–0.92
Limit of detection (mg/mL) 0.0463
Limit of quantitation (mg/mL) 0.1544
Speciﬁcity Speciﬁc
Solvent suitability Suitable for 24 h
aMeans Y¼bXþc, where ‘X’ is concentration in mg/mL and
Y is absorbance unit.
bSix replicate samples.
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The summary of method validation is given in Table 5. The
method was also found to be speciﬁc as no interference observed
when the drug was estimated in the presence of excipients. The
method was also rugged as there was no change in absorbance
up to 48 h of preparation of solution in the proposed solvent.
Limit of detection (LOD) and limit of quantiﬁcation (LOQ) were
found to be 0.0463 mg/mL and 0.1544 mg/mL, respectively.
Validation of the proposed method of analysis is conﬁrmed
statistically by low values of standard deviation, percent
coefﬁcient of variation and standard error. The proposedmethod is simple, rapid and precise. They do not suffer from
any interference due to common excipients of tablets. There-
fore, the developed method may be useful for routine analysis
of Lornoxicam in bulk drug and pharmaceutical dosage form
as shown in Table 2.4. Conclusion
The spectrophotometric method described in this paper achieves
the established pharmacopoeias requirements to be used as a
routine method for the quality control of pharmaceutical for-
mulations. The proposed validated method has advantage as it
used cheaper solvents in comparisons with other standard
methods and having accuracy, precision and sensitivity as good
as the methods used very expensive solvents.
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